BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 12098741)

  • 1. [Prevalence and relation of dyspepsia to irritable bowel syndrome in a native community of the Peruvian jungle].
    Curioso WH; Donaires Mendoza N; Bacilio Zerpa C; Ganoza Gallardo C; León Barúa R
    Rev Gastroenterol Peru; 2002; 22(2):129-40. PubMed ID: 12098741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of coexisting irritable bowel syndrome on symptoms and pathophysiological mechanisms in functional dyspepsia.
    Corsetti M; Caenepeel P; Fischler B; Janssens J; Tack J
    Am J Gastroenterol; 2004 Jun; 99(6):1152-9. PubMed ID: 15180740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and risk factors for overlaps between gastroesophageal reflux disease, dyspepsia, and irritable bowel syndrome: a population-based study.
    Lee SY; Lee KJ; Kim SJ; Cho SW
    Digestion; 2009; 79(3):196-201. PubMed ID: 19342860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiologic study of the irritable bowel syndrome in Beijing: stratified randomized study by cluster sampling.
    Pan G; Lu S; Ke M; Han S; Guo H; Fang X
    Chin Med J (Engl); 2000 Jan; 113(1):35-9. PubMed ID: 11775207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of upper digestive symptoms in patients with irritable bowel syndrome.
    Balboa A; Mearin F; Badía X; Benavent J; Caballero AM; Domínguez-Muñoz JE; Garrigues V; Piqué JM; Roset M; Cucala M; Figueras M;
    Eur J Gastroenterol Hepatol; 2006 Dec; 18(12):1271-7. PubMed ID: 17099375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Irritable bowel syndrome according to varying diagnostic criteria: are the new Rome II criteria unnecessarily restrictive for research and practice?
    Boyce PM; Koloski NA; Talley NJ
    Am J Gastroenterol; 2000 Nov; 95(11):3176-83. PubMed ID: 11095338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional dyspepsia and irritable bowel syndrome in patients with achalasia and its association with non-cardiac chest pain and a decreased health-related quality of life.
    Frankhuisen R; Van Herwaarden MA; Heijkoop R; Baron A; Vermeijden R; Smout AJ; Gooszen HG; Samsom M
    Scand J Gastroenterol; 2009; 44(6):687-91. PubMed ID: 19263270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Quality of life at dyspepsia and irritable bowel syndrome: population-based studies].
    Reshetnikov OV; Kurilovich SA; Simonova GI; Pylenkova ED; Maliutina SK
    Eksp Klin Gastroenterol; 2010; (3):27-31. PubMed ID: 20496786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concomitant functional dyspepsia and irritable bowel syndrome decrease health-related quality of life in gastroesophageal reflux disease.
    De Vries DR; Van Herwaarden MA; Baron A; Smout AJ; Samsom M
    Scand J Gastroenterol; 2007 Aug; 42(8):951-6. PubMed ID: 17613924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abdominal bloating in employed adults: prevalence, risk factors, and association with other bowel disorders.
    Tuteja AK; Talley NJ; Joos SK; Tolman KG; Hickam DH
    Am J Gastroenterol; 2008 May; 103(5):1241-8. PubMed ID: 18422817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Irritable bowel syndrome: a 10-yr natural history of symptoms and factors that influence consultation behavior.
    Ford AC; Forman D; Bailey AG; Axon AT; Moayyedi P
    Am J Gastroenterol; 2008 May; 103(5):1229-39; quiz 1240. PubMed ID: 18371141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [An epidemiologic study of irritable bowel syndrome in Beijing - a stratified randomized study by clustering sampling].
    Pan G; Lu S; Ke M; Han S; Guo H; Fang X
    Zhonghua Liu Xing Bing Xue Za Zhi; 2000 Feb; 21(1):26-9. PubMed ID: 11860753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional dyspepsia and irritable bowel syndrome: is there a common pathophysiological basis?
    Holtmann G; Goebell H; Talley NJ
    Am J Gastroenterol; 1997 Jun; 92(6):954-9. PubMed ID: 9177509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinical overlap between functional dyspepsia and irritable bowel syndrome based on Rome III criteria.
    Wang A; Liao X; Xiong L; Peng S; Xiao Y; Liu S; Hu P; Chen M
    BMC Gastroenterol; 2008 Sep; 8():43. PubMed ID: 18808723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dyspepsia and IBS symptoms in patients with NERD, ERD and Barrett's esophagus.
    Neumann H; Monkemuller K; Kandulski A; Malfertheiner P
    Dig Dis; 2008; 26(3):243-7. PubMed ID: 18463443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review article: epidemiology and quality of life in functional gastrointestinal disorders.
    Chang L
    Aliment Pharmacol Ther; 2004 Nov; 20 Suppl 7():31-9. PubMed ID: 15521853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology of constipation (EPOC) study in the United States: relation of clinical subtypes to sociodemographic features.
    Stewart WF; Liberman JN; Sandler RS; Woods MS; Stemhagen A; Chee E; Lipton RB; Farup CE
    Am J Gastroenterol; 1999 Dec; 94(12):3530-40. PubMed ID: 10606315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of irritable bowel syndrome in the French population according to the Rome I criteria.
    Bommelaer G; Dorval E; Denis P; Czernichow P; Frexinos J; Pelc A; Slama A; El Hasnaoui A
    Gastroenterol Clin Biol; 2002 Dec; 26(12):1118-23. PubMed ID: 12520200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Epidemiological study of functional bowel disorders in Iceland].
    Olafsdóttir LB; Gudjónsson H; Thjódleifsson B
    Laeknabladid; 2005 Apr; 91(4):329-33. PubMed ID: 16155326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Irritable bowel syndrome in patients with dyspepsia: a community-based study in southern Europe.
    Caballero-Plasencia AM; Sofos-Kontoyannis S; Valenzuela-Barranco M; Martín-Ruiz JL; Casado-Caballero FJ; López-Mañas JG
    Eur J Gastroenterol Hepatol; 1999 May; 11(5):517-22. PubMed ID: 10755255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.